The Annals Holiday Offer - Save 50%
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 27 March 2007, www.theannals.com, DOI 10.1345/aph.1H423.
 The Annals of Pharmacotherapy: Vol. 41, No. 4, pp. 674-680. DOI 10.1345/aph.1H423
© 2007 Harvey Whitney Books Company.
This Article
Right arrow Abstract Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow News Release
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horn, J. R
Right arrow Articles by Chan, L.-N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horn, J. R
Right arrow Articles by Chan, L.-N.

L'évaluation de la causalité lors d'une interaction médicamenteuse potentielle requiert la prise en considération des propriétés des médicaments impliqués, des facteurs spécifiques au patient, et de la possible contribution des autres médicaments que le patient consomme. L'algorithme de Naranjo a été conçu pour évaluer des effets indésirables aux médicaments seulement, et non des interactions entre médicaments. Plusieurs des questions de l'algorithme de Naranjo ne s'appliquent pas aux interactions entre médicaments alors que d'autres ne spécifient pas le médicament précipitant ou le médicament affecté. Néanmoins, il a été utilisé pour évaluer des interactions entre médicaments. L'échelle de probabilité des interactions médicamenteuses (EPIM) a été développée spécifiquement pour fournir un guide à l'évaluation de causalité des interactions médicamenteuses chez un patient donné. Son utilisation a été prévue pour assister les cliniciens dans l'évaluation des effets indésirables résultant des interactions médicamenteuses potentielles. L'EPIM utilise une série de questions ayant trait à une interaction médicamenteuse potentielle pour estimer un pointage de probabilité. Une évaluation précise par le biais de l'EPIM requiert la connaissance des propriétés pharmacologiques des 2 médicaments impliqués. Une connaissance inadéquate des médicaments impliqués ou encore des mécanismes de base des interactions médicamenteuses sera une limite pour certains utilisateurs. L'EPIM peut aussi servir de guide dans la rédaction des rapports de cas signalant une interaction médicamenteuse et dans l'évaluation des rapports de cas publiés.

Marie Larouche

www.theannals.com, DOI 10.1345/aph.1H423


This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
L. V. Moretti and R. O. Montalvo
Elevated International Normalized Ratio associated with concurrent use of sorafenib and warfarin
Am. J. Health Syst. Pharm., December 1, 2009; 66(23): 2123 - 2125.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
A. W. Chock, K. A Packard, and L. K Ohri
Comment: Fatal Intracranial Bleed Potentially Due to a Warfarin and Influenza Vaccine Interaction
Ann. Pharmacother., November 1, 2009; 43(11): 1913 - 1913.
[Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
J. A. Morales-Molina, M A. M. Arrebola, P. A. Robles, and J. C. Mangana
Possible Interaction Between Topical Terbinafine and Acenocoumarol
Ann. Pharmacother., November 1, 2009; 43(11): 1911 - 1912.
[Full Text] [PDF]

Home page
 J Clin PharmacolHome page
S. Haroutiunian, Y. Ratz, B. Rabinovich, M. Adam, and A. Hoffman
Valproic Acid Plasma Concentration Decreases in a Dose-Independent Manner Following Administration of Meropenem: A Retrospective Study
J. Clin. Pharmacol., November 1, 2009; 49(11): 1363 - 1369.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
W. Yamreudeewong, H. K. Wong, L. M Brausch, and K. R Pulley
Probable Interaction Between Warfarin and Marijuana Smoking
Ann. Pharmacother., July 1, 2009; 43(7): 1347 - 1353.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
Y. Y Tsao and J. J Gugger
Delirium in a Patient with Toxic Flecainide Plasma Concentrations: The Role of a Pharmacokinetic Drug Interaction with Paroxetine
Ann. Pharmacother., July 1, 2009; 43(7): 1366 - 1369.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
A. Garg and M. Mohammed
Decreased INR Response Secondary to Warfarin-Flucloxacillin Interaction
Ann. Pharmacother., July 1, 2009; 43(7): 1374 - 1375.
[Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
G. W. Allison, R. J. Perla, P. P. Belliveau, and S. M. Angelis
Elevated creatine phosphokinase levels associated with linezolid therapy
Am. J. Health Syst. Pharm., June 15, 2009; 66(12): 1097 - 1100.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
D. N Carroll and D. G Carroll
Fatal Intracranial Bleed Potentially Due to a Warfarin and Influenza Vaccine Interaction
Ann. Pharmacother., April 1, 2009; 43(4): 754 - 760.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
R. Yano, D. Tani, K. Watanabe, H. Tsukamoto, T. Igarashi, T. Nakamura, and M. Masada
Evaluation of Potential Interaction Between Vinorelbine and Clarithromycin
Ann. Pharmacother., March 1, 2009; 43(3): 453 - 458.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
A. H Burstein, E. A Boudreau, and W. H Theodore
Increase in Tiagabine Serum Concentration with Coadministration of Gemfibrozil
Ann. Pharmacother., February 1, 2009; 43(2): 379 - 382.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
D. L Parker, T. K Hoffmann, M. A. Tucker, and D. J Meier
Interaction Between Warfarin and Black Tea
Ann. Pharmacother., January 1, 2009; 43(1): 150 - 151.
[Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
J. Bird and C. Carmona
Probable Interaction Between Warfarin and Torsemide
Ann. Pharmacother., December 1, 2008; 42(12): 1893 - 1898.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
C.-M. Wong, Y. Ko, and A. Chan
Clinically Significant Drug-Drug Interactions Between Oral Anticancer Agents and Nonanticancer Agents: Profiling and Comparison of Two Drug Compendia
Ann. Pharmacother., December 1, 2008; 42(12): 1737 - 1748.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
K. A. Mergenhagen and O. Sherman
Elevated International Normalized Ratio after concurrent ingestion of cranberry sauce and warfarin
Am. J. Health Syst. Pharm., November 15, 2008; 65(22): 2113 - 2116.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
F. Pea, U. Baccarani, M. Tavio, P. Cojutti, G. L. Adani, A. Londero, M. Baraldo, L. Franceschi, M. Furlanut, and P. Viale
Pharmacokinetic Interaction Between Everolimus and Antifungal Triazoles in a Liver Transplant Patient
Ann. Pharmacother., November 1, 2008; 42(11): 1711 - 1716.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
S. R Vazquez, M. T Rondina, and R. C Pendleton
Azathioprine-Induced Warfarin Resistance
Ann. Pharmacother., July 1, 2008; 42(7): 1118 - 1123.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
M. K Cooper, D. G Brock, and C. M McDaniel
Interaction Between Levodopa and Enteral Nutrition
Ann. Pharmacother., March 1, 2008; 42(3): 439 - 442.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
D. Moellentin, C. Picone, and E. Leadbetter
Memantine-Induced Myoclonus and Delirium Exacerbated by Trimethoprim
Ann. Pharmacother., March 1, 2008; 42(3): 443 - 447.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
M. G. Scordo, H. Melhus, E. Stjernberg, A. M. Edvardsson, and M. Wadelius
Warfarin-Noscapine Interaction: A Series of Four Case Reports
Ann. Pharmacother., March 1, 2008; 42(3): 448 - 450.
[Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
H. CACI and F. BAYLE
A Case of Disulfiram-Methylphenidate Interaction: Implications for Treatment
Am J Psychiatry, November 1, 2007; 164(11): 1759 - 1759.
[Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
I. Spriet, J. Goyens, W. Meersseman, A. Wilmer, L. Willems, and W. V. Paesschen
Interaction Between Valproate and Meropenem: A Retrospective Study
Ann. Pharmacother., July 1, 2007; 41(7): 1130 - 1136.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow News Release
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horn, J. R
Right arrow Articles by Chan, L.-N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horn, J. R
Right arrow Articles by Chan, L.-N.

homecopy help contact us subscription past issues search current issue
Copyright © 2007 by Harvey Whitney Books Company.